[1]
Phan, H.M. et al. 2026. ASSESSMENT OF HEPATIC STEATOSIS BY ULTRASOUND-GUIDED ATTENUATION PARAMETER AND ATORVASTATIN TREATMENT OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Cantho Journal of Medicine and Pharmacy. 102 (Aug. 2026), 247–251. DOI:https://doi.org/10.58490/ctjump.2026i102.4804.